Philly Data-Mining Startup Cira Discovery Attracts Seed Funding, Proteomics Collaborator | GenomeWeb

Cira Discovery Sciences claims that its data-mining technology can bend and stretch to handle biosequence analysis, cheminformatics, and gene expression and SNP analysis. But rather than showcase its proprietary approach in one of these well-established analytical realms, Cira, a Philadelphia-based startup, has chosen the burgeoning, yet controversial, field of proteomics-based diagnostics for one of its first proof-of-principle collaborations. This week, the company announced a collaboration with the Wistar Institute to develop pattern-based diagnostics for lung cancer.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.